NRx Pharmaceuticals Inc (NRXPW) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.04
• Market Cap: $714.61M
• EPS: $-6.25
• 52-Week High: $0.17
• 52-Week Low: $0.03

About NRx Pharmaceuticals Inc

NRx Pharmaceuticals, Inc. (Ticker: NRXPW) is a clinical-stage biopharmaceutical firm headquartered in Wilmington, Delaware, dedicated to developing groundbreaking therapies for serious central nervous system disorders and lung diseases. The company is actively conducting advanced clinical trials to meet critical unmet medical needs, particularly in acute crises such as suicidal depression and respiratory ailments. With a strong commitment to improving patient outcomes and a promising pipeline...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NRx Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NRXPW pay dividends?

NRx Pharmaceuticals Inc (NRXPW) does not currently pay a regular dividend.

What is NRXPW's market cap?

NRx Pharmaceuticals Inc (NRXPW) has a market capitalization of $714.61M with a current stock price of $0.04.